From today, the Evrysdi (risdiplam) 5mg tablet is included on the PBS, broadening access to an important treatment option.
The tablet is available for people aged 2 years and older who weigh at least 20 kg, and can be swallowed whole or dispersed in a small amount of water.
Importantly, the tablet doesn’t require refrigeration, making treatment simpler for families and far more practical in everyday life.
SMA Australia welcomes this progress and continues to advocate for choice and equitable accessibility for Australians living with SMA.
Join a powerful community of supporters who are helping tackle spinal muscular atrophy at its very core. Our community relies on us for support and best-practice resources to guide them in living well with SMA, as well as for resources to help raise disease awareness, educate others and advocate for people living with SMA in the wider Australian community.
